|
🐜
|
Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis
9 auth.
L. Fabbri,
Samuel Moss,
F. Khan,
W. Chi,
Jun Xia,
K. Robinson,
...
A. Smyth,
G. Jenkins,
I. Stewart
|
6 |
2022 |
6
🐜
|
|
🐜
|
Genetic overlap between idiopathic pulmonary fibrosis and COVID−19
8 auth.
R. Allen,
B. Guillen-Guio,
Emma Croot,
L. M. Kraven,
Samuel Moss,
I. Stewart,
...
R. Jenkins,
L. Wain
|
5 |
2021 |
5
🐜
|
|
🐜
|
Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: A systematic review and meta-analysis.
9 auth.
Laura Fabbri,
Samuel Moss,
F. Khan,
Wenjie Chi,
Jun Xia,
Karen A. Robinson,
...
Alan R. Smyth,
Gisli Jenkins,
Iain A. Stewart
|
4 |
2021 |
4
🐜
|
|
🐜
|
Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysis
8 auth.
F. Khan,
Iain D Stewart,
Samuel Moss,
Laura Fabbri,
Karen A. Robinson,
Simon R Johnson,
...
R. G. Jenkins,
Ph.D R. Gisli Jenkins
|
3 |
2022 |
3
🐜
|
|
🐬
|
Shared genetic risk factors: implications for treatment of idiopathic pulmonary fibrosis and systemic hypertension
Gina Parcesepe,
R. Allen,
B. Guillen-Guio,
Samuel Moss,
R. Jenkins,
L. Wain
|
0 |
2023 |
0
🐬
|
|
🐜
|
Association between mosaic loss of chromosome Y and pulmonary fibrosis susceptibility and severity
14 auth.
Dapeng Wang,
Niran Hadad,
Samuel Moss,
Elena Lopez-Jimenez,
Simon R Johnson,
Toby M. Maher,
P. Molyneaux,
Yajie Zhao,
J. Perry,
P. Wolters,
...
J. Kropski,
Gisli Jenkins,
N. Banovich,
Iain D Stewart
|
0 |
2024 |
0
🐜
|
|
🐜
|
Shared genetic risk factors and their implications for treatment of IPF and systemic hypertension
8 auth.
Gina Parcesepe,
R. Allen,
B. Guillen-Guio,
Samuel Moss,
R. Jenkins,
V. Louise,
...
Wain,
Margaret Turner
|
0 |
2023 |
0
🐜
|
